Bartkowiak-Wieczorek, Joanna, Malesza, Michał, Malesza, Ida et al. · Nutrients · 2024 · DOI
This review examines a compound called 6-MSITC found in wasabi that may have anti-inflammatory and antioxidant properties. Laboratory and animal studies suggest it could help with several conditions including cancer, Alzheimer's disease, and obesity. However, this is primarily a review of existing research rather than a new clinical trial, and more human testing is needed before we know if it truly helps patients.
For ME/CFS patients and researchers, this review is tangentially relevant due to the compound's potential anti-inflammatory and antioxidant properties, which may address some proposed ME/CFS pathophysiology. However, the review focuses on cancer, Alzheimer's, and metabolic disease rather than ME/CFS specifically, so its direct applicability to ME/CFS is minimal.
This review does not prove that 6-MSITC is effective in humans for any condition tested, as it acknowledges limited human clinical data. The study cannot establish safety or efficacy from animal and in vitro studies alone, and provides no evidence of benefit specifically in ME/CFS patients. Importantly, a promising molecular mechanism does not guarantee clinical benefit in complex human diseases.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →